Impact of Non-invasive Neurally Adjusted Ventilatory Assist on Very Preterm Infants Born Between 27 and 32 Weeks Gestation
Led by Korea University Anam Hospital · Updated on 2026-08-05
80
Participants Needed
2
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
This observational study examines the effects of Non-invasive Neurally Adjusted Ventilatory Assist NIV-NAVA on very preterm infants born between 27 weeks 0 days and 31 weeks 6 days of gestation. The research aims to understand how NIV-NAVA influences short-term clinical outcomes and long-term brain development in these infants who need respiratory support shortly after birth.
Participants will receive respiratory assistance starting within 48 hours of birth using NIV-NAVA. The respiratory settings will be tailored to each infants condition and may change to other forms of support like nasal continuous airway pressure or high flow nasal cannula, or stop after initial stabilization. If infants develop respiratory distress syndrome, lung surfactant will be given using a less invasive method, and invasive ventilation may be used if necessary.
During the study, infants will be closely monitored for respiratory outcomes, including failure rates of NIV-NAVA and duration of ventilation. Researchers will also assess complications like bronchopulmonary dysplasia, brain injuries, and retinopathy. Brain imaging at term-equivalent age and developmental assessments up to 3 years will evaluate neurodevelopmental progress. The study follows infants through their hospital stay up to three months and includes long-term developmental follow-up.
CONDITIONS
Brief Title
Clinical Impact of Non-invasive Neurally Adjusted Ventilatory Assist in Very Preterm Infants
Research Team
J
Juyoung Lee, Professor
H
Hannah Cho, Professor
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Preterm infants born between 27 weeks 0 days to 31 weeks 6 days of gestation
Preterm infants who require respiratory support within the first 48 hours of life
You will not qualify if you...
Preterm infants who die within the first 48 hours of life
Preterm infants who do not require any respiratory support within the first 48 hours of life
Preterm infants with congenital anomalies affecting the lungs, heart, or other organs that could influence breathing
Infants whose parents do not consent to participate in the study
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Observation and Respiratory Support
Duration - Up to 3 months or until hospital discharge
Participants receive respiratory support with NIV-NAVA starting within 48 hours of birth. Respiratory settings may be adjusted or switched to other support methods as needed. Lung surfactant may be given if needed, and invasive ventilation is used if the condition worsens.
Regular monitoring during hospital stay
Neurodevelopmental Follow-up
Duration - Up to 3 years
Participants undergo brain imaging at term-equivalent age and developmental assessments up to 3 years old to evaluate long-term outcomes.
Scheduled developmental visits
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Using Bubble Continuous Positive Airway Pressure and Sound Monitoring to Measure Airway Pressure in Premature Infants
Study Comparing Air Temperature Control Versus Skin Servocontrol in Incubators for Preterm Infants Born Between 25 and 32 Weeks Gestation
Effects on Growth and Health During First 10 Days of Life
Impact of Non-invasive Neurally Adjusted Ventilatory Assist on Very Preterm Infants Born Between 27 and 32 Weeks Gestation
Evaluation of a Wireless Acoustic Sensor to Detect Respiratory Events in Infants Born Before 29 Weeks
Comparing Early Lung Development in Preterm Infants With and Without Intrauterine Growth Restriction
Study of Gut Microbiome Development in Preterm and Full-term Infants During Early Life
Improving Early Nutrition for Extremely and Very Preterm Infants Using a New Feeding and Supplement Plan
Feasibility Study of a Developmental Feeding Strategy for Preterm Infants in the NICU
Positive Feeding of the Preterm Infant with Parental Support and Individualized Care
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Feasibility of NIV-NAVA as a primary respiratory support and its clinical impacts in a targeted group of preterm infants: protocol for a prospective observational study.